Susquehanna Fundamental Investments, LLC Aim Immuno Tech Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$1.93 - $2.39 $32,810 - $40,630	-17,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.88 - $2.82 $6,016 - $9,024	-3,200 Reduced 15.84%	17,000 $39,000
Q4 2020 Feb 16, 2021	BUY	$1.68 - $2.45 $14,448 - $21,070	8,600 Added 74.14%	20,200 $36,000
Q2 2020 Aug 14, 2020	BUY	$1.9 - $2.94 $22,040 - $34,104	11,600 New	11,600 $29,000

8.42M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $12M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.